Kum Weng
11-03 07:42
[Symbol:GAB.SI|Amova STI ETF S$A (GAB.SI)] is an SGX-listed STI ETF, not an operating company. Therefore, company earnings, P/E, balance-sheet analysis and analyst targets are not meaningful for this instrument; its key driver is the performance of its underlying Singapore equity exposure.

View: Near-term price momentum is weak and oversold, while the longer 12-month return remains positive. This is more a broad Singapore-equity exposure assessment than a single-stock thesis.

Latest available close: S$5.101 on 2026-11-02; SGX had not opened on 2026-11-03. The ETF fell 1.14% on the day.
Trend: It is down 1.81% over 5 trading days, 6.49% over 20 days, 6.21% over 60 days and 6.88% over the quarter, but remains up 17.64% year-on-year.
52-week context: S$4.078–S$5.629. The latest price sits at the 65.96th percentile of that range and is 9.38% below the 52-week high—so it is not near the annual low despite the recent correction.
Technical condition: RSI(6) was 17.41 on 2026-11-02, a deeply

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment